Breaking News

You are here » Indian-Commodity  :  Top News  :  Aurobindo Pharma to launch 19 products in US in next three quarters

06-Sep2016

Aurobindo Pharma to launch 19 products in US in next three quarters

Aurobindo Pharma is planning to launch 19 approved products that have an addressable market of $6.8 billion in the US in the next three quarters. Moreover, the company has another 22 targeted 'action dates through the end of the financial year' although it does not 'anticipate all those will be final approvals but a significant number will be'.

Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.


Related News

View all news

Crude oil futures settle higher on Thursday

Extending gains for second straight session, crude oil futures settled higher on Thursday, despite official data from the Energy Information Administration (EIA) showing a bigger than expected increase......

Gold futures settle higher on weak dollar

Gold futures settled higher on Wednesday, rebounding from previous session's lowest finish. The yellow metal marked biggest one-day gain in nearly two weeks, as the dollar eased by 0.2 percent after hitting......

Copper futures end higher on Wednesday

Copper futures ended higher on Wednesday. Meanwhile, base metals on London Metal Exchange held steady as weak retail sales data from top consumer China took the shine off upbeat industrial output and investment......

Top News

View all news

Karnataka Bank launches CASA campaign

Karnataka Bank has launched Current & Savings Accounts campaign (CASA) of FY 2018-19 and introduced a new SB scheme 'KBL SB - TASC' a specialized product for Trusts/Associates/Societies/Clubs.Under......

M&M's arm opens manufacturing hub in Bengaluru

Mahindra & Mahindra's (M&M) subsidiary -- Mahindra Electric Mobility has opened its electric technology manufacturing hub set up with an investment of Rs 100 crore in Bengaluru. The plant......

Venus Remedies reports positive result in Phase-3 Clinical Trials for ELORES

Venus Remedies has reported positive Top-Line results in its Phase-3 Clinical Trials for its flagship product ELORES. The results were presented at IDWeek 2018 in San Francisco. IDWeek is an annual scientific......